CLRB - Cellectar Biosciences GAAP EPS of -$1.22 misses by $0.19
- Cellectar Biosciences press release ( NASDAQ: CLRB ): Q2 GAAP EPS of -$1.22 misses by $0.19 .
- As of June 30, 2022, the company had cash and cash equivalents of $24.8 million, compared to $35.7 million as of December 31, 2021.
For further details see:
Cellectar Biosciences GAAP EPS of -$1.22 misses by $0.19